ART (antiretroviral therapy)
GPTKB entity
Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:appointed_by |
injections
oral tablets clinical settings home settings |
| gptkbp:can_be_used_with |
other therapies
|
| gptkbp:caused_by |
side effects
|
| gptkbp:consists_of |
antiretroviral drugs
|
| gptkbp:developed_by |
HIV research
|
| gptkbp:has_impact_on |
quality of life
|
| https://www.w3.org/2000/01/rdf-schema#label |
ART (antiretroviral therapy)
|
| gptkbp:improves |
immune function
|
| gptkbp:is_associated_with |
improved survival rates
reduced morbidity |
| gptkbp:is_available_in |
various formulations
|
| gptkbp:is_evaluated_by |
effectiveness
clinical trials safety |
| gptkbp:is_influenced_by |
socioeconomic factors
|
| gptkbp:is_linked_to |
patient education
mental health support healthcare access issues social support networks adherence challenges |
| gptkbp:is_monitored_by |
healthcare providers
|
| gptkbp:is_part_of |
chronic disease management
global health initiatives integrated care models HIV prevention strategies public health strategies HIV care continuum HIV treatment guidelines HIV/ AIDS response strategies |
| gptkbp:is_promoted_by |
health campaigns
|
| gptkbp:is_protected_by |
HIV transmission
|
| gptkbp:is_subject_to |
policy changes
regulatory approval research funding stigma |
| gptkbp:is_supported_by |
community organizations
|
| gptkbp:is_used_for |
HIV treatment
|
| gptkbp:is_used_in |
resource-limited settings
|
| gptkbp:is_used_to |
manage opportunistic infections
prevent mother-to-child transmission treat co-infections |
| gptkbp:provides_information_on |
gptkb:municipality
|
| gptkbp:receives_funding_from |
gptkb:government_agency
non-profit organizations international agencies |
| gptkbp:reduces |
viral load
|
| gptkbp:requires |
adherence to medication
|
| gptkbp:suitable_for |
gptkb:CDC
gptkb:WHO people living with HIV |
| gptkbp:treatment |
gptkb:HIV/_AIDS
|
| gptkbp:bfsParent |
gptkb:abacavir
|
| gptkbp:bfsLayer |
5
|